Bionano Genomics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Bionano Genomics, Inc. announces a public offering of up to 2,032,520 shares of common stock, pre-funded warrants, and accompanying Series E and F warrants, aiming to raise approximately $9.0 million in net proceeds for working capital and general corporate purposes, while also disclosing a going concern risk.